All news

US tested hazardous bioproducts on patients in Kharkov in 2019-2021 — Russian top brass

According to Igor Kirillov, the individuals with mental disorders were selected for tests based on their age, ethnicity and immune status

MOSCOW, April 14. /TASS/. American scientists conducted the trials of potentially hazardous biological products on patients at the Kharkov regional clinical psychiatric hospital No. 3 from 2019 to 2021, Chief of Russia’s Nuclear, Biological and Chemical Protection Troops Igor Kirillov said.

"During the special operation in Ukraine, it has been established that during the period from 2019 to 2021, the American scientists from a laboratory in the town of Merefa (the Kharkov Region) conducted the trials of potentially hazardous biological products among the patients of the regional clinical psychiatric hospital No. 3 of the city of Kharkov," he said.

According to him, the individuals with mental disorders were selected for tests based on their age, ethnicity and immune status. "Special forms were recording the result of the round-the-clock monitoring of the patients’ condition. Information was not included in the hospital’s database, the staff of the medical facility signed a non-disclosure statement," the military official added.

He also noted that in January of 2022, the operations of the laboratory in Merefa were suspended, all equipment and biological products were taken to western Ukraine. "There are testimonies of a number of witnesses of these inhuman experiments whose names we cannot divulge in the interests of ensuring their safety," the chief of Russian nuclear, biological and chemical protection troops said.